Metabolic interactions of methoxsalen and coumarin in humans and mice.

Methoxsalen (8-methoxypsoralen) is a very potent inhibitor of human cytochrome P450 2A6 (CYP2A6) and mouse Cyp2a-5-mediated coumarin 7-hydroxylation in vitro. To determine the effect of methoxsalen on coumarin 7-hydroxylation in humans in vivo, five subjects were given 45 mg of methoxsalen and 5 mg of coumarin. Methoxsalen inhibited in vivo coumarin metabolism by 47 +/- 9.2% (mean +/- SEM). Methoxsalen was metabolized in human liver microsomes at the rate of 50-100 pmol/mg protein/min (approx. 30% of the activity in mouse liver microsomes). Metabolism was not inhibited by the anti-Cyp2a-5 antibody in human liver microsomes. NIH 3T3 cells stably expressing catalytically active CYP2A6 enzyme did not metabolize methoxsalen, indicating that CYP2A6 does not accept methoxsalen as a substrate. In pyrazole-induced mouse liver microsomes, methoxsalen metabolism was inhibited by the anti-Cyp2a-5 antibody. Cyp2a-5 protein expressed in the yeast Saccharomyces cerevisiae was capable of metabolizing methoxsalen, indicating that methoxsalen is a substrate of Cyp2a-5. Although kinetic studies indicated that the inhibition of coumarin 7-hydroxylation by methoxsalen is competitive in human liver microsomes, methoxsalen does not appear to be a substrate for CYP2A6. Methoxsalen and coumarin have the potential of strong metabolic interactions in man.

[1]  G. Moroff,et al.  Yeast glutathione reductase. Steady-state kinetic studies of its transhydrogenase activity. , 1976, Archives of biochemistry and biophysics.

[2]  M. Lang,et al.  Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes. , 1989, Archives of biochemistry and biophysics.

[3]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[4]  J. Idle,et al.  Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. , 1992, Journal of chromatography.

[5]  R. Mayer,et al.  Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[6]  M. Lang,et al.  Comparative studies on coumarin and testosterone metabolism in mouse and human livers. Differential inhibitions by the anti-P450Coh antibody and metyrapone. , 1991, Biochemical pharmacology.

[7]  D. Pessayre,et al.  Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. , 1987, Biochemical pharmacology.

[8]  M. A. Chambers,et al.  Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts. , 1990, The Journal of pharmacology and experimental therapeutics.

[9]  D. Mays,et al.  Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. , 1986, The Journal of pharmacology and experimental therapeutics.

[10]  O Pelkonen,et al.  Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. , 1992, Pharmacogenetics.

[11]  K. Vähäkangas,et al.  Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. , 1993, European journal of pharmacology.

[12]  M. Lang,et al.  Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. , 1988, European Journal of Biochemistry.

[13]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. , 1993, DNA and cell biology.

[14]  D. Pessayre,et al.  Inactivation of cytochrome P-450 by the drug methoxsalen. , 1986, The Journal of pharmacology and experimental therapeutics.

[15]  D. Nebert,et al.  Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. , 1968, The Journal of biological chemistry.

[16]  H. Yamazaki,et al.  Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. , 1992, Carcinogenesis.

[17]  H. Sigusch,et al.  Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. , 1993, Biochemical pharmacology.

[18]  J. S. Miles,et al.  Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. , 1990, The Biochemical journal.

[19]  P. Cheney,et al.  Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans , 1987, Clinical pharmacology and therapeutics.

[20]  A. Aitio.  A simple and sensitive assay of 7-ethoxycoumarin deethylation. , 1978, Analytical biochemistry.

[21]  M. A. Chambers,et al.  Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[22]  J. Voorhees,et al.  Psoralen photochemotherapy of cutaneous disorders. , 1980, Annual review of pharmacology and toxicology.

[23]  M. Lang,et al.  Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse. , 1989, Archives of biochemistry and biophysics.

[24]  T. Shimada,et al.  Purification and characterization of human liver microsomal cytochrome P-450 2A6. , 1991, Molecular pharmacology.

[25]  R. Lindberg,et al.  Alteration of high and low spin equilibrium by a single mutation of amino acid 209 in mouse cytochromes P450. , 1991, The Journal of biological chemistry.

[26]  R. Meehan,et al.  Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy. , 1988, The Biochemical journal.

[27]  F. A. de Wolff,et al.  Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients. , 1982, British journal of clinical pharmacology.

[28]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[29]  S. Otton,et al.  In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[30]  M. P. Arlotto,et al.  Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1 , 1990 .

[31]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[32]  T. Aoyama,et al.  Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. , 1991, Archives of biochemistry and biophysics.

[33]  J. Parrish,et al.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. , 1974, The New England journal of medicine.

[34]  F. Guengerich,et al.  Oxidation of quinidine by human liver cytochrome P-450. , 1986, Molecular pharmacology.

[35]  M. Lang,et al.  Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. , 1988, Biochemical pharmacology.

[36]  M. Ståhlberg,et al.  Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse. , 1990, Biochemical pharmacology.

[37]  S. Unger,et al.  Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[38]  O. Pelkonen,et al.  Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. , 1985, British journal of clinical pharmacology.

[39]  M. Lang,et al.  Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. , 1985, European journal of biochemistry.

[40]  D. Egan,et al.  The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. , 1990, Drug metabolism reviews.

[41]  R. Lindberg,et al.  Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue , 1989, Nature.